FundedIQ
Biotechnology

aTension.life: Funding, Investors & Team (Sep 2026)

aTension.life is a company dedicated to improving the diagnosis and treatment of hypertension using precision medicine. By utilizing advanced mass spectrometry technology, they can pinpoint the root causes of uncontrolled hypertension with just one blood sample. Their goal is to offer personalized diagnostic options for better patient care and assist laboratories with dependable tools. Ultimately, aTension.life strives to enhance the lives of hypertensive patients by making innovative diagnostics readily available and enabling tailored therapies for more effective treatment.

www.atension.life/# LinkedIn Osterreicher, Austria 11-50 employees
Biotechnology Health Care Health Diagnostics Medical Pharmaceutical B2C
Total raised
$3.0M
Rounds
1
Latest
Seed
Apr 2025

aTension.life has raised $3.0M across 1 funding round on record, the most recent a Seed of $3.0M announced in Apr 2025.

That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

aTension.life Company Profile and Key Stats

Total funding raised
$3.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Seed
$3.0M in Apr 2025
Employees
11-50
reported band
Headquarters
Osterreicher, Austria

Latest funding round on record: Apr 2025.

aTension.life Funding Rounds

Date
Round
Amount
Seed
$3.0M

aTension.life Founders and Leadership Team

Name
Role
Contact
Bernhard Klemen
Founder
Locked

Contact details for the aTension.life team: 1 of 1 has an email address on file.

Start 14-day free trial →

aTension.life Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
195
$4.0M
16,485
$3.1M

aTension.life's latest round of $3.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like aTension.life in Biotechnology and Osterreicher

Companies Similar to aTension.life

Graph is a precision immunology techbio that leverages perturbation modeling from primary patient cell…

Seed $5.0M

VALANX Biotech creates a unique method of attaching proteins to specific sites for use in treatments,…

Undisclosed round $3.5M

Millions of people worldwide suffer from brain-related issues that can already be addressed with the latest…

Undisclosed round $800k

Hookipa Biotech is a clinical stage company developing next-generation immunotherapies for infectious…

Undisclosed round $21.3M

The patented technology developed by Lignovations allows for the creation of lignin particles in the…

Seed $2.4M

Sarcura creates a machine platform for the mass production of customized cell therapies in industry. Our goal…

Seed $7.3M

Arkeon Bio is a biotechnology company that captures CO2 from industry and converts inorganic gases into…

Seed $7.1M

Celeris Therapeutics is a deep learning company that uses innovative, computer-based methods to degrade…

Seed $3.4M

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

MAASH is a biotech mycoprotein producing company that supply a nutritious and health feed and food protein…

Seed $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Adaptyv Biosystems developing a protein engineering platform using cell-free synthetic biology and…

Series A $40.0M

aTension.life Funding FAQs

What does aTension.life do?

aTension.life is a company dedicated to improving the diagnosis and treatment of hypertension using precision medicine. By utilizing advanced mass spectrometry technology, they can pinpoint the root causes of uncontrolled hypertension with just one blood sample. Their goal is to offer personalized diagnostic options for better patient care and assist laboratories with dependable tools. Ultimately, aTension.life strives to enhance the lives of hypertensive patients by making innovative diagnostics readily available and enabling tailored therapies for more effective treatment.

How much funding has aTension.life raised?

aTension.life has raised $3.0M across 1 round on record. The most recent is a Seed of $3.0M announced in Apr 2025.

When did aTension.life last raise funding?

aTension.life's most recent funding round on record is a Seed of $3.0M, announced in Apr 2025.

Who founded aTension.life?

FundedIQ lists Bernhard Klemen (Founder) at aTension.life.

Where is aTension.life headquartered?

aTension.life is based in Osterreicher, Steiermark, Austria.

How many employees does aTension.life have?

aTension.life is in the 11-50 employee band.

How does aTension.life's funding compare to other Biotechnology startups?

aTension.life's latest round of $3.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's aTension.life Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for aTension.life is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.